Literature DB >> 2991960

Purine nucleoside--mediated immobility in mice: reversal by antidepressants.

S K Kulkarni, A K Mehta.   

Abstract

In the forced swimming-induced immobility (despair) test model, adenosine, and 2-chloroadenosine treatment prolonged the immobilization period in mice. Dipyridamole, which is known to inhibit adenosine uptake, potentiated the adenosine effect. The purinoceptor antagonists caffeine and theophylline blocked purine nucleoside-induced enhancement of immobilization. Tricyclic antidepressants such as imipramine and desipramine, the MAO inhibitor tranylcypromine, and amphetamine, a psychostimulant, reversed purine nucleoside-induced immobility. On the other hand, quipazine, fluoxetine, and amitriptyline failed to reverse purine nucleosides-induced prolongation of immobility. None of the antidepressants in the doses investigated had any effect by themselves. Reserpine also prolonged forced swimming-induced immobility in mice. The antidepressants fluoxetine and quipazine, but not methylxanthine pretreatment, reversed reserpine-induced immobility in this test model. These results indicate that adenosine and 2-chloroadenosine probably reduce norepinephrine outflow through their action on presynaptic purinoceptors on noradrenergic neurons and thereby cause prolongation of immobility in animals.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991960     DOI: 10.1007/bf00429665

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  27 in total

1.  3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists.

Authors:  A CARLSSON; M LINDQVIST; T MAGNUSSON
Journal:  Nature       Date:  1957-11-30       Impact factor: 49.962

2.  Presynaptic inhibitory actions of adenine nucleotides and adenosine on neurotransmission in the rat vas deferens.

Authors:  A S Clanachan; A Johns; D M Paton
Journal:  Neuroscience       Date:  1977       Impact factor: 3.590

3.  Behavioural despair in rats: a new model sensitive to antidepressant treatments.

Authors:  R D Porsolt; G Anton; N Blavet; M Jalfre
Journal:  Eur J Pharmacol       Date:  1978-02-15       Impact factor: 4.432

4.  Mechanism of enchancement of adenosine action by dipyridamole and lidoflazine, in dogs.

Authors:  S Afonso; G S O'Brien
Journal:  Arch Int Pharmacodyn Ther       Date:  1971-11

5.  Similarities between the pharmacological actions of quipazine and serotonin.

Authors:  E Hong; L F Sancilio; R Vargas; E G Pardo
Journal:  Eur J Pharmacol       Date:  1969       Impact factor: 4.432

Review 6.  Adenosine receptors in the central nervous system: relationship to the central actions of methylxanthines.

Authors:  J W Daly; R F Bruns; S H Snyder
Journal:  Life Sci       Date:  1981-05-11       Impact factor: 5.037

7.  Adenosine and dipyridamole actions and interactions on isolated coronary artery strips of cattle.

Authors:  S Kalsner
Journal:  Br J Pharmacol       Date:  1975-11       Impact factor: 8.739

8.  The effect of diazepam and of agents which change GABAergic functions in immobility in mice.

Authors:  T Nagatani; T Sugihara; R Kodaira
Journal:  Eur J Pharmacol       Date:  1984-01-27       Impact factor: 4.432

9.  Effect of purinergic substances on rectal temperature in mice: involvement of P1-purinoceptors.

Authors:  A K Mehta; S K Kulkarni
Journal:  Arch Int Pharmacodyn Ther       Date:  1983-08

10.  "Behavioural despair" in rats and mice: strain differences and the effects of imipramine.

Authors:  R D Porsolt; A Bertin; M Jalfre
Journal:  Eur J Pharmacol       Date:  1978-10-01       Impact factor: 4.432

View more
  17 in total

1.  GABA-mediated modification of despair behavior in mice.

Authors:  K O Aley; S K Kulkarni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-03       Impact factor: 3.000

2.  Clonidine--induced behavioural despair in mice: reversal by antidepressants.

Authors:  M P Parale; S K Kulkarni
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 3.  Is the forced swimming test a suitable model for revealing antidepressant activity?

Authors:  F Borsini; A Meli
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice.

Authors:  M El Yacoubi; C Ledent; M Parmentier; R Bertorelli; E Ongini; J Costentin; J M Vaugeois
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

5.  Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A₁ and A2A receptor activation.

Authors:  Mauricio P Cunha; Francis L Pazini; Julia M Rosa; Ana B Ramos-Hryb; Ágatha Oliveira; Manuella P Kaster; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2015-02-22       Impact factor: 3.765

6.  Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences.

Authors:  Baldeep Kumar; Anurag Kuhad; Kanwaljit Chopra
Journal:  Psychopharmacology (Berl)       Date:  2010-11-20       Impact factor: 4.530

7.  Urtica dioica extract attenuates depressive like behavior and associative memory dysfunction in dexamethasone induced diabetic mice.

Authors:  Sita Sharan Patel; Malairaman Udayabanu
Journal:  Metab Brain Dis       Date:  2014-01-17       Impact factor: 3.584

8.  Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition.

Authors:  Hai-Ying Shen; Jiang-Fan Chen
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 9.  Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

Authors:  Rodrigo A Cunha; Sergi Ferré; Jean-Marie Vaugeois; Jiang-Fan Chen
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

10.  Antidepressant activity of curcumin: involvement of serotonin and dopamine system.

Authors:  Shrinivas K Kulkarni; Mohit Kumar Bhutani; Mahendra Bishnoi
Journal:  Psychopharmacology (Berl)       Date:  2008-09-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.